CROWELL & MORING LLP for CARDINAL HEALTH, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Healthcare, tax, and labor issues related to pharmaceuticals and medical products and services: LIFO inventory accounting method; HR 6, 21st Century Cures/Senate Medical Innovation bills; 2016 Consolidated Appropriations Act, moratorium on the medical device excise tax; CMS 2016 proposed Medicare Part B payment reforms; implementation of the Puerto Rico Oversight, Management, and Economic Stability Act; general issues regarding prescription drug abuse; American Medical Isotopes Production Act of 2012, Section 2, Improving the Reliability of Domestic Medical Isotope Supply; general issues related to the pharmaceutical and medical products supply chain; VA Next Generation Medical Surgical Prime Vendor Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT DOUGLAS New | Finance Director, Sen. McConnell |
| JAMES FLOOD New | Counsel, Senate Judiciary Committee, Sen. Schumer |
| MICHAEL GILL New | Legislative Aide for Gillmor, Greenwood, Danforth |
Taxation/Internal Revenue Code TAX
Healthcare, tax, and labor issues related to pharmaceuticals and medical products and services: LIFO inventory accounting method; HR 6, 21st Century Cures/Senate Medical Innovation bills; 2016 Consolidated Appropriations Act, moratorium on the medical device excise tax; CMS 2016 proposed Medicare Part B payment reforms; implementation of the Puerto Rico Oversight, Management, and Economic Stability Act; general issues regarding prescription drug abuse; American Medical Isotopes Production Act of 2012, Section 2, Improving the Reliability of Domestic Medical Isotope Supply; general issues related to the pharmaceutical and medical products supply chain; VA Next Generation Medical Surgical Prime Vendor Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT DOUGLAS New | Finance Director, Sen. McConnell |
| JAMES FLOOD New | Counsel, Senate Judiciary Committee, Sen. Schumer |
| MICHAEL GILL New | Legislative Aide for Gillmor, Greenwood, Danforth |
Health Issues HCR
Healthcare, tax, and labor issues related to pharmaceuticals and medical products and services: LIFO inventory accounting method; HR 6, 21st Century Cures/Senate Medical Innovation bills; 2016 Consolidated Appropriations Act, moratorium on the medical device excise tax; CMS 2016 proposed Medicare Part B payment reforms; implementation of the Puerto Rico Oversight, Management, and Economic Stability Act; general issues regarding prescription drug abuse; American Medical Isotopes Production Act of 2012, Section 2, Improving the Reliability of Domestic Medical Isotope Supply; general issues related to the pharmaceutical and medical products supply chain; VA Next Generation Medical Surgical Prime Vendor Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT DOUGLAS New | Finance Director, Sen. McConnell |
| JAMES FLOOD New | Counsel, Senate Judiciary Committee, Sen. Schumer |
| MICHAEL GILL New | Legislative Aide for Gillmor, Greenwood, Danforth |
Medicare/Medicaid MMM
Healthcare, tax, and labor issues related to pharmaceuticals and medical products and services: LIFO inventory accounting method; HR 6, 21st Century Cures/Senate Medical Innovation bills; 2016 Consolidated Appropriations Act, moratorium on the medical device excise tax; CMS 2016 proposed Medicare Part B payment reforms; implementation of the Puerto Rico Oversight, Management, and Economic Stability Act; general issues regarding prescription drug abuse; American Medical Isotopes Production Act of 2012, Section 2, Improving the Reliability of Domestic Medical Isotope Supply; general issues related to the pharmaceutical and medical products supply chain; VA Next Generation Medical Surgical Prime Vendor Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT DOUGLAS New | Finance Director, Sen. McConnell |
| JAMES FLOOD New | Counsel, Senate Judiciary Committee, Sen. Schumer |
| MICHAEL GILL New | Legislative Aide for Gillmor, Greenwood, Danforth |
Pharmacy PHA
Healthcare, tax, and labor issues related to pharmaceuticals and medical products and services: LIFO inventory accounting method; HR 6, 21st Century Cures/Senate Medical Innovation bills; 2016 Consolidated Appropriations Act, moratorium on the medical device excise tax; CMS 2016 proposed Medicare Part B payment reforms; implementation of the Puerto Rico Oversight, Management, and Economic Stability Act; general issues regarding prescription drug abuse; American Medical Isotopes Production Act of 2012, Section 2, Improving the Reliability of Domestic Medical Isotope Supply; general issues related to the pharmaceutical and medical products supply chain; VA Next Generation Medical Surgical Prime Vendor Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT DOUGLAS New | Finance Director, Sen. McConnell |
| JAMES FLOOD New | Counsel, Senate Judiciary Committee, Sen. Schumer |
| MICHAEL GILL New | Legislative Aide for Gillmor, Greenwood, Danforth |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.